scispace - formally typeset
M

Min Sun

Researcher at Hubei University of Medicine

Publications -  33
Citations -  612

Min Sun is an academic researcher from Hubei University of Medicine. The author has contributed to research in topics: Cancer & Internal medicine. The author has an hindex of 11, co-authored 29 publications receiving 392 citations. Previous affiliations of Min Sun include Wuhan University.

Papers
More filters
Journal ArticleDOI

miR-195-5p/NOTCH2-mediated EMT modulates IL-4 secretion in colorectal cancer to affect M2-like TAM polarization

TL;DR: miR-195-5p may play a vital role in regulating NOTCH2-mediated tumor cell EMT, thereby affecting IL-4-related M2-like TAM polarization in CRC.
Journal ArticleDOI

Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer

TL;DR: The integrated microRNA profiling approach identified miR-195-5p independently associated with prognosis in CRC as a potent suppressor of YAP1, and miR/YAP1 downregulation significantly reduced tumor development in a mouse CRC xenograft model.
Journal ArticleDOI

An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network

TL;DR: The eight-lncRNA signature could serve as an independent biomarker for prediction of overall survival of BRCA and the lncRNA-miRNA-mRNA ceRNA network is a good tool to identify lncRNAs that is correlated with overall survival.
Journal ArticleDOI

Integrated Analysis Identifies a Nine-microRNA Signature Biomarker for Diagnosis and Prognosis in Colorectal Cancer.

TL;DR: Inhibition of miR-200a-3p function contributed to abnormal colony formation, migration, invasion, and epithelial–mesenchymal transition of CRC cells and was determined to be a potential diagnostic and prognostic biomarker for CRC.
Journal ArticleDOI

Identifying biomarkers of papillary renal cell carcinoma associated with pathological stage by weighted gene co-expression network analysis

TL;DR: These hub genes may serve as a biomarker and help to distinguish different pathological stages for PRCC patients and be associated with patient prognosis.